Annual EBIT
-$18.23 M
+$8.42 M+31.61%
01 December 2023
Summary:
Quantum BioPharma annual earnings before interest & taxes is currently -$18.23 million, with the most recent change of +$8.42 million (+31.61%) on 01 December 2023. During the last 3 years, it has risen by +$9.99 million (+35.39%).QNTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$4.00 M
-$660.90 K-19.76%
01 September 2024
Summary:
Quantum BioPharma quarterly earnings before interest & taxes is currently -$4.00 million, with the most recent change of -$660.90 thousand (-19.76%) on 01 September 2024. Over the past year, it has dropped by -$1.21 million (-43.05%).QNTM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$11.08 M
-$1.21 M-12.21%
01 September 2024
Summary:
Quantum BioPharma TTM earnings before interest & taxes is currently -$11.08 million, with the most recent change of -$1.21 million (-12.21%) on 01 September 2024. Over the past year, it has increased by +$13.32 million (+54.58%).QNTM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QNTM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.6% | -43.0% | +54.6% |
| 3 y3 years | +35.4% | +28.6% | +65.0% |
| 5 y5 years | -9.3% | +63.7% | +70.8% |
QNTM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | -234.2% | >+9999.0% |
Quantum BioPharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.00 M(+19.8%) | -$11.08 M(+12.2%) |
| June 2024 | - | -$3.34 M(+60.9%) | -$9.87 M(-17.9%) |
| Mar 2024 | - | -$2.08 M(+25.9%) | -$12.02 M(-39.6%) |
| Dec 2023 | -$18.23 M(-31.6%) | -$1.65 M(-41.0%) | -$19.90 M(-18.4%) |
| Sept 2023 | - | -$2.80 M(-49.0%) | -$24.40 M(-15.0%) |
| June 2023 | - | -$5.49 M(-44.9%) | -$28.71 M(-7.9%) |
| Mar 2023 | - | -$9.96 M(+61.9%) | -$31.17 M(+16.9%) |
| Dec 2022 | -$26.65 M(-21.3%) | -$6.15 M(-13.6%) | -$26.65 M(+0.1%) |
| Sept 2022 | - | -$7.11 M(-10.5%) | -$26.64 M(+6.0%) |
| June 2022 | - | -$7.95 M(+46.0%) | -$25.14 M(-16.0%) |
| Mar 2022 | - | -$5.44 M(-11.2%) | -$29.93 M(-11.6%) |
| Dec 2021 | -$33.87 M(+20.0%) | -$6.13 M(+9.3%) | -$33.87 M(+7.0%) |
| Sept 2021 | - | -$5.61 M(-55.9%) | -$31.67 M(-17.5%) |
| June 2021 | - | -$12.74 M(+35.7%) | -$38.39 M(+30.1%) |
| Mar 2021 | - | -$9.39 M(+138.8%) | -$29.52 M(+4.6%) |
| Dec 2020 | -$28.22 M | -$3.93 M(-68.1%) | -$28.22 M(-20.8%) |
| Sept 2020 | - | -$12.34 M(+220.0%) | -$35.63 M(+3.8%) |
| June 2020 | - | -$3.86 M(-52.3%) | -$34.33 M(-16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$8.09 M(-28.7%) | -$41.22 M(+21.2%) |
| Dec 2019 | -$33.93 M(+103.5%) | -$11.35 M(+2.8%) | -$34.01 M(-10.3%) |
| Sept 2019 | - | -$11.04 M(+2.7%) | -$37.93 M(+58.7%) |
| June 2019 | - | -$10.75 M(+1129.4%) | -$23.91 M(+48.8%) |
| Mar 2019 | - | -$874.10 K(-94.3%) | -$16.06 M(-10.5%) |
| Dec 2018 | -$16.67 M(+494.9%) | -$15.27 M(-611.5%) | -$17.94 M(+570.1%) |
| Sept 2018 | - | $2.99 M(-202.8%) | -$2.68 M(-52.8%) |
| June 2018 | - | -$2.90 M(+7.0%) | -$5.67 M(+104.9%) |
| Mar 2018 | - | -$2.71 M(+6840.9%) | -$2.77 M(+5072.7%) |
| Feb 2018 | - | -$39.10 K(+666.7%) | -$53.50 K(+123.8%) |
| Dec 2017 | -$2.80 M(>+9900.0%) | - | - |
| Nov 2017 | - | -$5100.00(-16.4%) | -$23.90 K(+21.9%) |
| Aug 2017 | -$19.40 K(-34.5%) | -$6100.00(+90.6%) | -$19.60 K(-27.4%) |
| May 2017 | - | -$3200.00(-66.3%) | -$27.00 K(-13.7%) |
| Feb 2017 | - | -$9500.00(+1087.5%) | -$31.30 K(+43.6%) |
| Nov 2016 | - | -$800.00(-94.1%) | -$21.80 K(+3.8%) |
| Aug 2016 | -$29.60 K(-9.8%) | -$13.50 K(+80.0%) | -$21.00 K(+180.0%) |
| May 2016 | - | -$7500.00 | -$7500.00 |
| Aug 2015 | -$32.80 K | - | - |
FAQ
- What is Quantum BioPharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Quantum BioPharma?
- What is Quantum BioPharma annual EBIT year-on-year change?
- What is Quantum BioPharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Quantum BioPharma?
- What is Quantum BioPharma quarterly EBIT year-on-year change?
- What is Quantum BioPharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Quantum BioPharma?
- What is Quantum BioPharma TTM EBIT year-on-year change?
What is Quantum BioPharma annual earnings before interest & taxes?
The current annual EBIT of QNTM is -$18.23 M
What is the all time high annual EBIT for Quantum BioPharma?
Quantum BioPharma all-time high annual earnings before interest & taxes is -$19.40 K
What is Quantum BioPharma annual EBIT year-on-year change?
Over the past year, QNTM annual earnings before interest & taxes has changed by +$8.42 M (+31.61%)
What is Quantum BioPharma quarterly earnings before interest & taxes?
The current quarterly EBIT of QNTM is -$4.00 M
What is the all time high quarterly EBIT for Quantum BioPharma?
Quantum BioPharma all-time high quarterly earnings before interest & taxes is $2.99 M
What is Quantum BioPharma quarterly EBIT year-on-year change?
Over the past year, QNTM quarterly earnings before interest & taxes has changed by -$1.21 M (-43.05%)
What is Quantum BioPharma TTM earnings before interest & taxes?
The current TTM EBIT of QNTM is -$11.08 M
What is the all time high TTM EBIT for Quantum BioPharma?
Quantum BioPharma all-time high TTM earnings before interest & taxes is -$7500.00
What is Quantum BioPharma TTM EBIT year-on-year change?
Over the past year, QNTM TTM earnings before interest & taxes has changed by +$13.32 M (+54.58%)